A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache
Public ClinicalTrials.gov record NCT06132529. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Biomarker Signature to Predict the Persistence of Post-traumatic Headache
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research study is to develop a model to help distinguish patients at high-risk for developing persistent post-traumatic headache from patients who experience headache recovery. Researchers will do this by comparing the brain images, clinical data, and speech of healthy controls to people who have been diagnosed with post-traumatic headache.
Study identification
- NCT ID
- NCT06132529
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 151 participants
Conditions and interventions
Conditions
Interventions
- Brain Magnetic Resonance Imaging (MRI) Scan Diagnostic Test
- Speech Sample Other
- Electronic Daily Headache Diary Other
Diagnostic Test · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 3, 2019 (Actual)
- Primary completion
- Jul 31, 2025 (Actual)
- Completion
- Jul 31, 2025 (Actual)
- Last update posted
- Aug 29, 2025
2019 – 2025
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VA Health Care System | Phoenix | Arizona | 85012 | — |
| Mayo Clinic Arizona | Phoenix | Arizona | 85054 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06132529, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 29, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06132529 live on ClinicalTrials.gov.